Reuters logo
BRIEF-Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone
November 1, 2017 / 12:43 PM / a month ago

BRIEF-Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone

Nov 1 (Reuters) - Resverlogix Corp

* Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone

* Resverlogix - ‍independent DSMB recommended phase 3 study of Apabetalone should continue as planned without modifications ​

* Resverlogix Corp - ‍full enrollment for phase 3 study of apabetalone now anticipated in first half of 2018​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below